Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: Secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) study

American Heart Journal

Volumn 145, Issue 6, 2003, Pages 1030-1035

  Jørgensen, Bjørn ^a,b   Thaulow, Erik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Beerum Sykehus   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; NISOLDIPINE; PLACEBO;

ADULT; AMBULATORY MONITORING; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; NONPARAMETRIC TEST; RECURRENT DISEASE; RISK; STENT;

AMLODIPINE; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RECURRENCE; STATISTICS, NONPARAMETRIC; STENTS;

EID: 0037606197     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00082-6     Document Type: Article

References (34)

1. Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61-8.
2. Rosing DR, van Raden MJ, Mincemoyer RM, et al. Exercise, electrocardiographic and functional responses after percutaneous transluminal coronary angioplasty. Am J Cardiol 1984;53:36-41C.
3. Chahine TA, Giles TD, Nicod P, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993;21:1365-70.
4. Deanfield JE, Detry J-M, Lichtlen PR, et al. Amlodipine reduces myocardial ischemia in patients with coronary artery disease: double-blind circadian anti-ischemia program in Europe (CAPE trial). J Am Coll Cardiol 1994;24:1460-7.
5. Davis RF, Habibullah H, Klinke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995;25:619-25.
6. Ezekowitz MD, Hossack K, Mehta JL, et al. Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J 1995;129:527-35.
7. Steffensen R, Melchior T, Bech J, et al. Effects of amlodipine and isosorbide dinitrate on exercise-induced and ambulatory ischemia in patients with chronic stable angina pectoris. Cardiovasc Drugs Ther 1997;11:629-35.
8. Knight CJ, Fox KM. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Am J Cardiol 1998;81:133-6.
9. Jørgensen B, Simonsen S, Endresen K, et al. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REstenosis Study (CAPARES). J Am Coll Cardiol 2000;35:591-9.
10. Crow RS, Rautoharju PM, Prineas RJ, et al. Risk factors, exercise fitness and electrocardiographic response to exercise in 12,866 men at high risk of symptomatic coronary disease. Am J Cardiol 1986;57:1075-83.
11. Gordon DJ, Leon AS, Ekelund LG, et al. Smoking, physical activity, and other predictors of endurance and heart rate response to exercise in asymptomatic hypercholesterolemic men: the lipid research clinics coronary primary prevention trial. Am J Epidemiol 1987;125:587-600.
12. Jørgensen B, Endresen K, Forfang K, et al. Attenuated physical exercise capacity in smokers compared with non-smokers after coronary angioplasty despite similar luminal diameters. Eur Heart J 1998;19:737-41.
13. Jørgensen B, Simonsen S, Forfang K, et al. Effect of percutaneaus transluminal coronary angioplasty on exercise in patients with and without previous myocardial infarction. Am J Cardiol 1998;82:1030-3.
14. Jørgensen B, Simonsen S, Endresen K, et al. Physiological response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis by exercise capacity. Am Heart J 2000;139:482-90.
15. Foley DP, Melkert R, Umans VA, et al. Differences in restenosis propensity of devices for transluminal coronary intervention: a quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups. Eur Heart J 1995;16:1331-46.
16. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
17. Serruys PW, Rutsch W, Heyndrickx GR, et al. Prevention of restenosis after percutaneaus transluminal coronary angioplasty with thrombaxane A2-receptor blockode. Circulation 1991;84:1568-80.
18. MERCATOR study group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneaus transluminal coronary angioplasty? Circulation 1992;86:100-10.
19. Roth A, Eschar Y, Keren G, et al. Effect of magnesium on restenosis after percutaneaus transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population. Eur Heart J 1994;15:1164-73.
20. Weintraub WS, Boccuzzi SJ, Klein L, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
21. Serruys PW, Foley DP, Jackson G, et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty. Eur Heart J 1999;20:58-69.
22. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-95.
23. Serruys PW, Foley DP, Pieper M, et al. The TRAPIST study. Eur Heart J 2001;22:1938-47.
24. Gimbrone MAJ. Endothelial dysfunction, hemodynamic forces and atherosclerosis. Thromb Haemost 1999;82:722-6.
25. Glagov S, Zarins C, Giddens DP, et al. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988;112:1018-31.
26. Marcus ML, Harrison DG, White CW, et al. Assessing the physiologic significance of coronary obstructions in patients: importance of diffuse undetected atherosclerosis. Prog Cardiovasc Dis 1988;31:39-56.
27. Hasdai D, Cannan CR, Mathew V, et al. Evaluation of patients with minimally obstructive coronary disease and angina. Int J Cardiol 1996;53:203-8.
28. Dens AJ, Desmet WJ, Coussement P, et al. Usefulness of nisodipine for prevention of restenosis after percutaneous transluminal coronary angioplasty (results of the NICOLE study). Am J Cardiol 2001;87:28-33.
29. Deanfield JE, Detry J-M, Lichtlen PR, et al. Amlodipine reduces myocardial ischemia in patients with coronary artery disease: double-blind circadian anti-ischemia program in Europe (CAPE trial). J Am Coll Cardiol 1994;24:1460-7.
30. Davis RF, Habibullah H, Klinke WP, et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995;25:619-25.
31. Dunselman HJM, van Kempen LHJ, Bouwens LHM, et al. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade. Am J Cardiol 1998;81:128-32.
32. Knight CJ, Fox KM. Amlodipine versus diltiazem as additional antianginal treatment to atenolol. Am J Cardiol 1998;81:133-6.
33. Deedwania PC. Anti-ischemic effects of amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life. Amlodipine Study Group. Am J Cardiol 1999;83:1117-9.
34. Pehrsson SK, Ringqvist I, Ekdahl S, et al. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. Clin Cardiol 2000;23:763-70.